Skip to main content

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

Objective

Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major adaptations to current paradigms of bringing medicines to patients are required in order to realize that potential and to address important challenges in the healthcare ecosystem.
Against this background, several initiatives are exploring new pathways to market, collectively referred to as Medicines Adaptive Pathways to Patients (MAPPs).
The ADAPT-SMART consortium is aligning a limited number of major stakeholders eager to progress towards MAPPs implementation. It will act as a neutral collaborative platform that will engage industry, SMEs, regulators, Health Technology Assessment bodies (HTAs), payers, governments, clinicians and patients.
The ADAPT-SMART consortium will contribute to align understanding of the impact of MAPPs, to share learnings between all stakeholders, and to allow the field to actively work towards MAPPs implementation.
The impact of the ADAPT-SMART CSA will be a result of the delivery of
• actionable advice/recommendations to IMI on how to best leverage results from past/current projects;
• concrete proposals for future (IMI) projects;
• actionable advice/recommendations and information to other actors in the healthcare environment;
• synthesis of learnings from pilot projects and case studies with relevance to MAPPs;
• communication of CSA outcomes by way of publications and conference presentations.
This CSA will increase the probability of successful implementation of MAPPs and accelerate access to crucial therapies, thus improving the position of both the patients in need of novel treatments and the research-based pharmaceutical industry.

Call for proposal

H2020-JTI-IMI2-2015-04-two-stage
See other projects for this call

Funding Scheme

IMI2-CSA - Coordination & support action

Coordinator

STICHTING LYGATURE
Address
Jaarbeursplein 6
3521 AL Utrecht
Netherlands
Activity type
Other
EU contribution
€ 522 000

Participants (34)

SUNDHEDSSTYRELSEN

Participation ended

Denmark
EU contribution
€ 0
Address
Islands Brygge 67
2300 Kobenhavn
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
FORUM EUROPEEN DES PATIENTS (FPE)
Luxembourg
EU contribution
€ 78 000
Address
Rue Dicks 14
1417 Luxembourg
Activity type
Other
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
United States
EU contribution
€ 0
Address
Massachusetts Avenue 77
02139 Cambridge
Activity type
Higher or Secondary Education Establishments
THE EUROPEAN MEDICINES AGENCY
Netherlands
EU contribution
€ 0
Address
Domenico Scarlattilaan 6
1083 HS Amsterdam
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom
EU contribution
€ 135 500
Address
Wellington Square University Offices
OX1 2JD Oxford
Activity type
Higher or Secondary Education Establishments
EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION
France
EU contribution
€ 78 000
Address
Rue Didot 96
75014 Paris
Activity type
Other
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
United Kingdom
EU contribution
€ 232 500
Address
Level 1A City Tower Piccadilly Plaza
M1 4BT Manchester
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
HAUTE AUTORITE DE SANTE
France
EU contribution
€ 28 000
Address
Avenue Du Stade De France 5
93218 Saint Denis La Plaine Cedex
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
ZORGINSTITUUT NEDERLAND
Netherlands
EU contribution
€ 28 000
Address
Eekholt 4
1112XH Diemen
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
BRISTOL-MYERS SQUIBB COMPANY CORP

Participation ended

United States
EU contribution
€ 0
Address
Park Avenue 345
10154 New York
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
AbbVie Ltd
United Kingdom
EU contribution
€ 0
Address
Vanwall Road
SL6 4XE Maidenhead
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
AMGEN
Belgium
EU contribution
€ 0
Address
Telecomlaan 5-7
1831 Diegem
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ASTELLAS PHARMA EUROPE LTD
United Kingdom
EU contribution
€ 0
Address
2000 Hillswood Drive
KT16 0RS Chertsey
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ASTRAZENECA AB
Sweden
EU contribution
€ 0
Address
Vastra Maelarhamnen
151 85 Sodertaelje
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Bayer Pharma AG
Germany
EU contribution
€ 0
Address
Muellerstrasse 178
13353 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
BOEHRINGER INGELHEIM INTERNATIONALGMBH
Germany
EU contribution
€ 0
Address
Binger Strasse
55218 Ingelheim
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
United Kingdom
EU contribution
€ 0
Address
Great West Road 980
TW89GS Brentford
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
IPSEN INNOVATION SAS
France
EU contribution
€ 0
Address
Avenue Du Canada - Zone Industrielle De Courtaboeuf 5
91940 Les Ulis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 0
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Eli Lilly and Company Limited
United Kingdom
EU contribution
€ 0
Address
Lilly House, Priestley Road
RG24 9NL Basingstoke
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
H. LUNDBECK AS
Denmark
EU contribution
€ 0
Address
Ottiliavej 7-9
2500 Valby
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LYSOGENE
France
EU contribution
€ 0
Address
18-20 Rue Jacques Dulud
92200 Neuilly Sur Seine
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
Germany
EU contribution
€ 0
Address
Frankfurter Strasse 250
64293 Darmstadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MERCK SHARP & DOHME CORP
United States
EU contribution
€ 0
Address
One Merck Drive
08889 Whitehouse Station Nj
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NOVARTIS PHARMA AG
Switzerland
EU contribution
€ 0
Address
Lichtstrasse 35
4056 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NOVO NORDISK A/S
Denmark
EU contribution
€ 0
Address
Novo Alle 1
2880 Bagsvaerd
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
PFIZER LIMITED
United Kingdom
EU contribution
€ 0
Address
Ramsgate Road
CT13 9NJ Sandwich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
F. HOFFMANN-LA ROCHE AG
Switzerland
EU contribution
€ 0
Address
Grenzacherstrasse 124
4070 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
France
EU contribution
€ 0
Address
Pierre Brossolette 1
91380 Chilly Mazarin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UCB BIOPHARMA SRL
Belgium
EU contribution
€ 0
Address
Allee De La Recherche 60
1070 Bruxelles
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES
Belgium
EU contribution
€ 0
Address
Rue Du Trone 108/1
1050 Bruxelles
Activity type
Other
AGENZIA ITALIANA DEL FARMACO
Italy
EU contribution
€ 28 000
Address
Via Del Tritone 181
00187 Roma
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS
France
EU contribution
€ 0
Address
Rue Carnot 50
92284 Courbevoie
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SHIRE INTERNATIONAL GMBH
Switzerland
EU contribution
€ 0
Address
Zahlerweg 10
6300 Zug
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)